Register for final places for excellent EACPT summer cardiovascular focus meeting 3-5 July in Holland

You are still in time to register for 2014 EACPT Focus Meeting on ‘Drugs to Fight Cardiovascular Damage’ from organised by the the European Association for Clinical Pharmacology and Therapeutics [EACPT] .Registration  – with a preferential accommodation rate – is available through the Focus Meeting website.The 2014 EACPT Focus Meeting takes place from July 3rd – 5th at the Radboud University Medical Center in Nijmegen in the Netherlands.Reasons to come to this outstanding meeting

excellent tradition of EACPT in providing outstanding meetings for young and senior clinicians and researchers
great opportunities for networking with your peers and senior members of the international clinical pharmacology community
easy access to senior researchers on the international speaker faculty 
opportunity to have first hand news on major developments for EACPT
meet Dr Richard Shader, the editor of the EACPT’s Official Journal – Clinical Therapeutics 
expert session from Dr Shader on how to publish

In addition to state-of-the-art lectures from international cardiovascular experts, over 60 delegate abstracts are due be presented  from around the world.…

Drug Discovery of the Year 2015 opens for nominations

21 May 2014, London UK: The British Pharmacological Society is now accepting nominations from anyone in the world for its third Drug Discovery of the Year award.

The award was established by the Society in 2012 to demonstrate the importance of pharmacology in the development of new medicines, and to reward the achievements of the teams of scientists who discover and develop these drugs.…

Geneva Congress 2013

Under the auspices of the Swiss Society of Clinical Pharmacology and Toxicology, the 11th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics took place in Geneva between the 28th and the 31st of August 2013 and was co-chaired by Pierre Dayer, Marie Besson and Caroline Samer.

The Geneva Congress brought together around 600 international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs.…